Idera Pharmaceuticals Inc
NASDAQ:IDRA
Income Statement
Earnings Waterfall
Idera Pharmaceuticals Inc
Revenue
|
4.9m
USD
|
Operating Expenses
|
-24.4m
USD
|
Operating Income
|
-19.5m
USD
|
Other Expenses
|
-3.8m
USD
|
Net Income
|
-23.4m
USD
|
Income Statement
Idera Pharmaceuticals Inc
Dec-2020 | Dec-2021 | Dec-2022 | ||
---|---|---|---|---|
Revenue | ||||
Revenue |
0
N/A
|
0
N/A
|
5
N/A
|
|
Operating Income | ||||
Operating Expenses |
(37)
|
(26)
|
(24)
|
|
Selling, General & Administrative |
(12)
|
(10)
|
(12)
|
|
Research & Development |
(25)
|
(16)
|
(12)
|
|
Operating Income |
(37)
N/A
|
(26)
+28%
|
(20)
+26%
|
|
Pre-Tax Income | ||||
Interest Income Expense |
0
|
7
|
1
|
|
Non-Reccuring Items |
0
|
(1)
|
(8)
|
|
Total Other Income |
(76)
|
119
|
(2)
|
|
Pre-Tax Income |
(113)
N/A
|
98
N/A
|
(30)
N/A
|
|
Net Income | ||||
Tax Provision |
0
|
0
|
6
|
|
Income from Continuing Operations |
(113)
|
98
|
(23)
|
|
Net Income (Common) |
(113)
N/A
|
97
N/A
|
(23)
N/A
|
|
EPS (Diluted) |
-56.63
N/A
|
32.88
N/A
|
-7.18
N/A
|